Tempus AI Revenue 2023-2025 | TEM

Tempus AI annual/quarterly revenue history and growth rate from 2023 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Tempus AI revenue for the quarter ending March 31, 2025 was $0.256B, a 75.38% increase year-over-year.
  • Tempus AI revenue for the twelve months ending March 31, 2025 was $0.803B, a 42.93% increase year-over-year.
  • Tempus AI annual revenue for 2024 was $0.693B, a 30.38% increase from 2023.
  • Tempus AI annual revenue for 2023 was $0.532B, a 65.85% increase from 2022.
  • Tempus AI annual revenue for 2022 was $0.321B, a 0% decline from .
Tempus AI Annual Revenue
(Millions of US $)
2024 $693
2023 $532
2022 $321
Tempus AI Quarterly Revenue
(Millions of US $)
2025-03-31 $256
2024-12-31 $201
2024-09-30 $181
2024-06-30 $166
2024-03-31 $146
2023-12-31 $148
2023-09-30 $136
2023-06-30 $132
2023-03-31 $116
2022-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $10.733B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.813B 60.83
Hims & Hers Health (HIMS) United States $13.134B 136.46
Doximity (DOCS) United States $11.457B 53.04
IRhythm Technologies (IRTC) United States $4.377B 0.00
Inspire Medical Systems (INSP) United States $3.856B 60.24
Hinge Health (HNGE) United States $3.535B 0.00
Privia Health (PRVA) United States $2.402B 164.17
10x Genomics (TXG) United States $1.803B 0.00
Schrodinger (SDGR) United States $1.643B 0.00
Phreesia (PHR) United States $1.614B 0.00
Azenta (AZTA) United States $1.562B 72.62
Enovis (ENOV) United States $1.561B 8.70
Clover Health Investments (CLOV) United States $1.527B 0.00
Omnicell (OMCL) United States $1.358B 23.97
Evolent Health (EVH) United States $1.133B 96.50
Claritev (CTEV) United States $0.664B 0.00
Fulgent Genetics (FLGT) United States $0.549B 0.00
Standard BioTools (LAB) United States $0.539B 0.00
Veradigm (MDRX) United States $0.507B 0.00
Butterfly Network (BFLY) United States $0.480B 0.00
Talkspace (TALK) United States $0.428B 128.00
TruBridge (TBRG) United States $0.347B 771.00
Outset Medical (OM) United States $0.320B 0.00
Health Catalyst (HCAT) United States $0.285B 0.00
Nyxoah SA (NYXH) Belgium $0.244B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.224B 0.00
CapsoVision (CV) United States $0.202B 0.00
Zepp Health (ZEPP) Netherlands $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.157B 0.00
American Well (AMWL) United States $0.136B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.123B 0.00
MDxHealth SA (MDXH) Belgium $0.120B 0.00
CareCloud (CCLD) United States $0.104B 3.95
ImmunoPrecise Antibodies (IPA) Canada $0.092B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.080B 0.00
111 (YI) China $0.061B 0.00
P3 Health Partners (PIII) United States $0.050B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
PROFUSA (PFSA) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00